Lifescience Research, Development, and Technology

We Develop Applications and Services to Help the Most Vulnerable Segment of Our Society Live Better Based on Sound Innovation, Research, Development, Design, and Engineering Principles

Prototypes in Research and Development

INFECTIOUS DISEASES

Biosensors for COVID -19 Detection

Biosensor for Infectious Diseases Detect the Presence of Chemicals by Using a Living Organism or Biological Molecules

Infectious diseases are disorders caused by various groups of organisms, such as bacteria, viruses, fungi, or parasites. Probiotics and different types of organisms live in and out of the body; they are used by the body to perform various functions like digestion- they do not cause any disease typically…

AI Technology for Diabetes

Throughout the Advancement of Diabetes Care, Artificial Intelligence Has Played a Significant Role Ranging from Prevention Approaches to Personalized Care

About 415 million people worldwide have diabetes, although 46% remain undiagnosed and untreated. Artificial Intelligence (AI) cannot battle with diabetes on its own, and in the fight against prevention and management…

AI For Hypertension

AI in Hypertension High Blood Pressure

Blood pressure is a major global public health issue raising the risk of stroke, cardiac and renal diseases. Hypertension causes other health complications, including some infections. Advances in artificial intelligence (AI) have helped people control medical problems such as hypertension and provided supportive and personalized treatment…

Our Current Work

Self-Service and Point-of-Care Testing for Covid-19 Leveraging Block-Chain and AI Enabled Automation

Early detection, treatment and surveillance of infectious diseases is crucial to enable outbreak control. Therefore, diagnostic and monitoring tools such as point-of-care (POC) or self-service tests must be integrated with effective surveillance and control measures to limit the spread of infection, particularly in high disease burdened areas with insufficient laboratory capacity.

Using the available clinical data, artificial intelligence (AI) methods enabled by blockchain technology can contribute to advancement of infectious diseases point of care testing.